24СʱÈÈÃŰæ¿éÅÅÐаñ    

Znn3bq.jpeg
²é¿´: 616  |  »Ø¸´: 2
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û1´Î£¬×÷Õßraoqun20Ôö¼Ó½ð±Ò 1 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

raoqun20

ľ³æ (ÖªÃû×÷¼Ò)


[×ÊÔ´] »ùÒòÓ¢Óïרҵ´Ê»ã

A
ÏÙÜÕÍѰ±Ã¸È±·¦Ö¢ adenosine deaminase deficiency (ADA)
ÏÙ²¡¶¾ adenovirus
Alagille×ÛºÏÕ÷ Alagille syndrome
µÈλ»ùÒò allele
°±»ùËá amino acids
¶¯ÎïÄ£ÐÍ animal model
¿¹Ìå antibody
µòÍö apoptosis
·-°Í×ÛºÏÕ÷ ataxia-telangiectasia
³£È¾É«ÌåÏÔÐÔ autosomal dominant
³£È¾É«Ìå autosome
B
ϸ¾úÈ˹¤È¾É«Ìå bacterial artificial chromosome (BAC)
¼î»ù¶Ô base pair
ÏÈÌìȱÏÝ birth defect
¹ÇËèÒÆÖ² bone marrow transplantation
BRCA1/BRCA2
C
°© cancer
ºóÑ¡»ùÒò candidate gene
°© carcinoma
cDNAÎÄ¿â cDNA library
ϸ°û cell
ȾɫÌå chromosome
¿Ë¡ cloning
ÃÜÂë codon
ÌìÉúµÄ congenital
ÖØµþȺ contig
ÄÒÐÔÏËά»¯ cystic fibrosis
ϸ°ûÒÅ´«Í¼ cytogenetic map
D
ȱʧ deletion
ÍÑÑõºËÌǺËËá deoxyribonucleic acid (DNA)
ÌÇÄò²¡ diabetes mellitus
¶þ±¶Ìå diploid
DNA¸´ÖÆ DNA replication
DNA²âÐò DNA sequencing
ÏÔÐ﵀ dominant
Ë«ÂÝÐý double helix
¸´ÖÆ duplication
E
µçÓ¾ electrophoresis
Ellis - van Creveld syndrome
ø enzyme
ÍâÏÔ×Ó exon
F
¼Ò×åÐÔµØÖк£ÈÈ familial Mediterranean fever
Ó«¹âԭλÔÓ½» fluorescence in situ hybridization (FISH)
´àÐÔXȾɫÌå×ÛºÏÕ÷ Fragile X syndrome
G
»ùÒò gene
»ùÒòÀ©Ôö gene amplification
»ùÒò±í´ï gene expression
»ùÒòͼÆ× gene mapping
»ùÒò¿â gene pool
»ùÒòÖÎÁÆ gene therapy
»ùÒò×ªÒÆ gene transfer
ÒÅ´«ÃÜÂë genetic code (ATGC)
ÒÅ´«×Éѯ genetic counseling
ÒÅ´«Í¼ genetic map
ÒÅ´«±ê¼Ç genetic marker
ÒÅ´«²¡É¸²é genetic screening
»ùÒò×é genome
»ùÒòÐÍ genotype
ÖÖϵ germ line
H
µ¥±¶Ìå haploid
haploinsufficiency
ÔìѪ¸Éϸ°û hematopoietic stem cell
ѪÓѲ¡ hemophilia
ÔÓºÏ×Ó heterozygous
¸ß¶È±£ÊØÐòÁÐ highly conserved sequence
Hirschsprung²¡ Hirschsprung's disease
´¿ºÏ×Ó homozygous
È˹¤È¾É«Ìå human artificial chromosome (HAC)
ÈËÀà»ùÒò×鼯»® Human Genome Project
ÈËÀàÃâÒßȱÏݲ¡¶¾ human immunodeficiency virus (HIV)/
»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷ acquired immunodeficiency syndrome (AIDS)
huntingtonÎ赸²¡ Huntington's disease
ÔÓ½» hybridization
I
ÃâÒßÖÎÁÆ immunotherapy
ԭλÔÓ½» in situ hybridization
¼Ì³ÐµÄ inherited
²åÈë insertion
֪ʶ²úȨ intellectual property rights
K
Çóý knockout
L
°×Ѫ²¡ leukemia
¿â library
¼ü¡¢Á¬½Ó linkage
²¿Î»¡¢³¡Ëù locus
ÓÅÊÆ¶ÔÊýÆÀ·Ö LOD score
ÁܰÍϸ°û lymphocyte
M
»ûÐÎ malformation
Ãèͼ mapping
񈬀 marker
ºÚÉ«ËØÁö melanoma
Ãϵ¶û Mendel, Johann (Gregor)
Ãϵ¶ûÒÅ´« Mendelian inheritance
ÐÅʹRNA messenger RNA (mRNA)
[·ÖÁÑ]ÖÐÆÚ metaphase
΢Õó¼¼Êõ microarray technology
ÏßÁ¢ÌåDNA mitochondrial DNA
µ¥ÌåÐÔ monosomy
СÊóÄ£ÐÍ mouse model
¶à·¢ÐÔÄÚ·ÖÃÚÁö²¡ multiple endocrine neoplasia, type 1 (MEN1)
Í»±ä mutation
N
Éñ¾­ÏËάÁö²¡ neurofibromatosis
ÄáÂü-Ƥ¿Ë²¡ Niemann-Pick disease, type C (NPC)
non-directiveness
RNAÓ¡¼Ç Northern blot
ºËÜÕËá nucleotide
Éñ¾­ºË nucleus
O
¹ÑºËÜÕËá oligo
°©»ùÒò oncogene
P
p53
Parkinson²¡ Parkinson's disease
רÀûȨ patent
Ѫϵ/Æ×ϵ pedigree
±íÐÍ phenotype
ÎïÀíͼÆ× physical map
¶àÖ¸»ûÐÎ/¶àÖº»ûÐÎ polydactyly
¾ÛºÏøÁ´·´Ó¦ polymerase chain reaction (PCR)
¶à̬ÐÔ polymorphism
¶¨Î»¿Ë¡ positional cloning
Ô­·¢ÐÔÃâÒßȱÏÝ primary immunodeficiency
ÒýÎï primer
Ô­ºË pronucleus
ǰÁÐÏÙ°© prostate cancer
µ°°× protein
R
ÒþÐÔ recessive
Äæ×ªÂ¼²¡¶¾ retrovirus
ºËÌǺËËá ribonucleic acid (RNA)
ºËÌÇÌå ribosome
risk communication
S
ÐòÁбê¼Çλµã sequence-tagged site (STS)
ÁªºÏÃâÒßȱÏÝ severe combined immunodeficiency (SCID)
ÐÔȾɫÌå sex chromosome
°éÐ﵀ sex-linked
Ìåϸ°û somatic cells
DNAÓ¡¼Ç Southern blot
¹âÆ×ºËÐÍ spectral karyotype (SKY)
Ìæ´ú substitution
×Ôɱ»ùÒò suicide gene
×ÛºÏÕ÷ syndrome
T
¼¼ÊõתÈà technology transfer
ת»ùÒòµÄ transgenic
Ò×λ translocation
ÈýÌåÐÍ trisomy
Ö×ÁöÒÖÖÆ»ùÒò tumor suppressor gene
V
ÔØÌå vector
W
µ°°×ÖÊÓ¡¼Ç Western blot
Wolfram×ÛºÏÕ÷ Wolfram syndrome
Y
½ÍĸÈ˹¤È¾É«Ìå yeast artificial chromosome (YAC)
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½­Á÷¶ù

ľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¶àл¥Ö÷Ãâ·Ñ·ÖÏí£¡£¡£¡
2Â¥2007-05-17 21:47:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÉòѦÄþ

Òø³æ (СÓÐÃûÆø)


ÉϵÄÊ»¯Ñ§£¬ÏÖÔÚÒª²¹ÉúÎïÁË
3Â¥2007-05-20 01:24:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ raoqun20 µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸Õã´óÉúÎï325·ÖÇóµ÷¼Á +7 zysheng 2026-04-12 7/350 2026-04-12 20:15 by bljnqdcc
[¿¼ÑÐ] ÉúÎïѧ308Çóµ÷¼Á +5 ÏàÐűػá¹ââÍòÕ 2026-04-11 5/250 2026-04-12 18:14 by zhouxiaoyu
[¿¼ÑÐ] ҩѧÇóµ÷¼Á +3 RussHu 2026-04-12 4/200 2026-04-12 17:49 by ³ÂƤƤ
[¿¼ÑÐ] 291Çóµ÷¼Á +8 ¹ØÒä±±. 2026-04-11 8/400 2026-04-12 09:32 by ÄæË®³Ë·ç
[»ù½ðÉêÇë] ɽ¶«Ê¡»ù½ð2026 +5 jerry681 2026-04-08 6/300 2026-04-12 08:33 by kudofaye
[¿¼ÑÐ] 305Çóµ÷¼Á +7 Â꿨°Í¿¨boom 2026-04-11 7/350 2026-04-12 07:35 by zhouxiaoyu
[¿¼ÑÐ] 327Çóµ÷¼Á +5 ʰ¹âÈÎȾ 2026-04-06 5/250 2026-04-12 02:29 by Çï¶¹²ËÑ¿
[¿¼ÑÐ] 291·Öµ÷¼Á +5 Éϰ¶Ð¡Ó¨¼ÓÓÍ 2026-04-09 6/300 2026-04-11 21:06 by ÄæË®³Ë·ç
[¿¼ÑÐ] µ÷¼Á +6 ÇàµÆ²»¸º 2026-04-09 6/300 2026-04-11 20:35 by dongdian1
[¿¼ÑÐ] ũѧ0904 312Çóµ÷¼Á +3 Say Never 2026-04-11 3/150 2026-04-11 17:22 by daydayup2005
[¿¼ÑÐ] 283Çóµ÷¼Á +22 ÄǸöàà×Ó 2026-04-09 22/1100 2026-04-11 10:41 by ÄæË®³Ë·ç
[¿¼ÑÐ] ÖÐҩѧµ÷¼Á ³õÊÔ324 +4 Ñó¸Ê¾Õ¡¢ 2026-04-10 6/300 2026-04-11 09:41 by gong120082
[¿¼ÑÐ] 273Çóµ÷¼Á +51 ÂóС¶£µ± 2026-04-06 58/2900 2026-04-10 15:54 by jiajinhpu
[¿¼ÑÐ] 282£¬µçÆø¹¤³Ìרҵ£¬Çóµ÷¼Á£¬²»Ìôרҵ +9 jggshjkkm 2026-04-10 9/450 2026-04-10 14:55 by ÄæË®³Ë·ç
[¿¼ÑÐ] Òѵ÷¼Á +18 ²ñ¿¤Ã¨_ 2026-04-09 19/950 2026-04-09 22:10 by ²ñ¿¤Ã¨_
[¿¼ÑÐ] ±¾¿ÆÖ£ÖÝ´óѧ£¬Ò»Ö¾Ô¸»ª¶«Ê¦·¶´óѧ282Çóµ÷¼Á +23 Ðܸçxtk 2026-04-07 26/1300 2026-04-09 17:17 by 18446523
[¿¼ÑÐ] ÉúÎïѧ328·ÖÇóµ÷¼Á +9 ÉÁµçkkl 2026-04-08 10/500 2026-04-08 21:42 by liuhuiying09
[¿¼ÑÐ] Çóµ÷¼Á£¬ÏÖÔÚ»¹ÄÜÌîµÄ +3 Éϰ¶Ð¡Ó¨¼ÓÓÍ 2026-04-08 3/150 2026-04-08 14:30 by zhq0425
[¿¼ÑÐ] 388Çóµ÷¼Á +6 ËÄ´¨ÍõÌÎ 2026-04-07 8/400 2026-04-08 00:17 by JourneyLucky
[¿¼ÑÐ] 328Çóµ÷¼Á +4 ghhh88888 2026-04-06 5/250 2026-04-07 14:45 by ghhh88888
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û